A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
NCT ID: NCT01461993
Last Updated: 2018-12-19
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
2499 participants
INTERVENTIONAL
2011-09-28
2013-07-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
rLP2086 + Gardasil
rLP2086 and Gardasil
Gardasil vaccine and rLP2086 injection will be given to the subject concomitantly in Group 1 at Months 0, 2 and 6.
Group 2
rLP2086 and saline
rLP2086
Injections of rLP2086 and saline will be given to the subject concomitantly in Group 2 at Months 0, 2 and 6.
Group 3
Saline + Gardasil
Gardasil
Injections of saline and Gardasil vaccine will be given to the subject concomitantly in Group 3 at Months 0, 2 and 6.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rLP2086 and Gardasil
Gardasil vaccine and rLP2086 injection will be given to the subject concomitantly in Group 1 at Months 0, 2 and 6.
rLP2086
Injections of rLP2086 and saline will be given to the subject concomitantly in Group 2 at Months 0, 2 and 6.
Gardasil
Injections of saline and Gardasil vaccine will be given to the subject concomitantly in Group 3 at Months 0, 2 and 6.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject must be healthy which will be determined by obtaining subject's medical history, receiving a physical examination and by judgment of the investigator.
Exclusion Criteria
* Previous vaccination with any HPV vaccine.
* Contraindication to vaccination with Gardasil or any HPV vaccine.
11 Years
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Coastal Clinical Research Inc.
Daphne, Alabama, United States
Radiant Research, Inc.
Chandler, Arizona, United States
The Children's Clinic of Jonesboro, PA
Jonesboro, Arkansas, United States
Arkansas Pediatric Clinic
Little Rock, Arkansas, United States
West Coast Clinical Trials, LLC
Cypress, California, United States
Pediatric Care Medical Group
Huntington Beach, California, United States
Loma Linda University Health Care - Moreno Valley Pediatrics
Moreno Valley, California, United States
Bayview Research Group, LLC
Paramount, California, United States
Center for Clinical Trials, LLC
Paramount, California, United States
California Research Foundation
San Diego, California, United States
Bayview Research Group, LLC
Valley Village, California, United States
Lynn Institute of the Rockies
Colorado Springs, Colorado, United States
Colorado Springs Family Practice
Colorado Springs, Colorado, United States
Miami Research Associates
Miami, Florida, United States
Pediatrics and Adolescent Medicine, PA
Marietta, Georgia, United States
Clinical Research Atlanta
Stockbridge, Georgia, United States
Pediatrics and Adolescent Medicine
Woodstock, Georgia, United States
Advanced Clinical Research
Meridian, Idaho, United States
Northpoint Pediatrics, LLC
Indianapolis, Indiana, United States
Heartland Research Associates, LLC
Wichita, Kansas, United States
Kentucky Pediatric/Adult Research
Bardstown, Kentucky, United States
Central Kentucky Research Associates, Inc.
Lexington, Kentucky, United States
Brownsboro Park Pediatrics
Louisville, Kentucky, United States
Bluegrass Clinical Research, Inc.
Louisville, Kentucky, United States
Allina Health Bandana Square Clinic
Saint Paul, Minnesota, United States
Aspen Medical Group / Odyssey Research
Saint Paul, Minnesota, United States
The Center for Pharmaceutical Research, PC
Kansas City, Missouri, United States
Mercy Health Research
St Louis, Missouri, United States
Sundance Clinical Research, LLC
St Louis, Missouri, United States
Sundance Clinical Research
St Louis, Missouri, United States
Midwest Children's Health Research Institute
Lincoln, Nebraska, United States
Quality Clinical Research, Inc.
Omaha, Nebraska, United States
Clinical Research Center of Nevada
Henderson, Nevada, United States
Clinical Research Center of Nevada
Henderson, Nevada, United States
Clinical Research Center of Nevada
Las Vegas, Nevada, United States
Rochester Clinical Research, Inc.
Rochester, New York, United States
Rochester Clinical Research
Rochester, New York, United States
SUNY Upstate Medical University
Syracuse, New York, United States
Cary Pediatric Center
Cary, North Carolina, United States
Duke University Medical Center - Duke Health Center
Durham, North Carolina, United States
Durham Pediatrics
Durham, North Carolina, United States
Duke Health Center
Durham, North Carolina, United States
PMG Research of Raleigh, LLC
Raleigh, North Carolina, United States
PMG Research of Raleigh, LLC
Raleigh, North Carolina, United States
Wake Internal Medicine Consultants, Inc
Raleigh, North Carolina, United States
Wake Research Associates
Raleigh, North Carolina, United States
Innovis Health, LLC dba Essentia Health South University Clinic
Fargo, North Dakota, United States
Cincinnati Children's Hospital Medical Center (CCHMC)
Cincinnati, Ohio, United States
Cincinnati Children's Hospital Medical Center (CCHMC)
Cincinnati, Ohio, United States
Senders Pediatrics
Cleveland, Ohio, United States
Rapid Medical Research, Inc.
Cleveland, Ohio, United States
Lynn Institute of Norman (LION)
Norman, Oklahoma, United States
Lynn Health Science Institute
Oklahoma City, Oklahoma, United States
Oklahoma State University - Center for Health Sciences - Pediatric Research Houston Center
Tulsa, Oklahoma, United States
Oklahoma State University - Center for Health Sciences Houston Parke Physicians
Tulsa, Oklahoma, United States
Preferred Primary Care Physicians, Inc.
Carnegie, Pennsylvania, United States
Liberty Family Practice
Erie, Pennsylvania, United States
Pennridge Pediatric Associates
Sellersville, Pennsylvania, United States
Richard K. Ohnmacht, MD
Cranston, Rhode Island, United States
Omega Medical Research
Warwick, Rhode Island, United States
Charleston Pediatrics
Charleston, South Carolina, United States
Coastal Carolina Research Center
Mt. Pleasant, South Carolina, United States
PMG Research of Charleston
Mt. Pleasant, South Carolina, United States
Clinical Research Associates, Inc.
Nashville, Tennessee, United States
Benchmark Research
Austin, Texas, United States
The Office of Dr. Roberta Braun, MD
Austin, Texas, United States
Advances In Health, Inc.
Houston, Texas, United States
Pediatric Healthcare of Northwest Houston
Houston, Texas, United States
Texas Center for Drug Development, Inc.
Houston, Texas, United States
University of Texas Medical Branch Pediatric Specialty Center
League City, Texas, United States
Benchmark Research
San Angelo, Texas, United States
Clinical Trials Of Texas, Inc
San Antonio, Texas, United States
Clinical Trials of Texas
San Antonio, Texas, United States
First Steps Pediatrics
San Antonio, Texas, United States
Radiant Research, Inc.
San Antonio, Texas, United States
Pediatric Healthcare of Northwest Houston, PA
Tomball, Texas, United States
Pediatric Healthcare of Northwest Houston
Tomball, Texas, United States
Murray Pediatrics
Murray, Utah, United States
Jean Brown Research
Salt Lake City, Utah, United States
Pediatric Associates of Charlottesville
Charlottesville, Virginia, United States
West Office - Pediatric Associates of Charlottesville
Charlottesville, Virginia, United States
North Office - Pediatric Associates of Charlottesville
Charlottesville, Virginia, United States
Clinical Research Associates of Tidewater
Norfolk, Virginia, United States
Advanced Pediatrics
Vienna, Virginia, United States
The Vancouver Clinic
Vancouver, Washington, United States
The Vancouver Clinic
Vancouver, Washington, United States
Monroe Clinic
Monroe, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Beeslaar J, Mather S, Absalon J, Eiden JJ, York LJ, Crowther G, Maansson R, Maguire JD, Peyrani P, Perez JL. Safety data from the MenB-FHbp clinical development program in healthy individuals aged 10 years and older. Vaccine. 2022 Mar 15;40(12):1872-1878. doi: 10.1016/j.vaccine.2022.01.046. Epub 2022 Feb 11.
Beeslaar J, Peyrani P, Absalon J, Maguire J, Eiden J, Balmer P, Maansson R, Perez JL. Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data. Infect Dis Ther. 2020 Sep;9(3):625-639. doi: 10.1007/s40121-020-00322-5. Epub 2020 Jul 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6108A1-2007
Identifier Type: OTHER
Identifier Source: secondary_id
B1971011
Identifier Type: -
Identifier Source: org_study_id